These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23676511)
21. Assessment of the surface contamination of the primary packaging of oral antineoplastic drugs and secondary packaging of chemotherapy preparations at a Swiss hospital. Nguyen N; Vallet V; Bouchoud L; Falaschi L; Rudaz S; Bonnabry P; Fleury-Souverain S J Oncol Pharm Pract; 2024 May; ():10781552241250010. PubMed ID: 38751088 [TBL] [Abstract][Full Text] [Related]
22. Validated method using liquid chromatography-electrospray ionization tandem mass spectrometry for the determination of contamination of the exterior surface of vials containing platinum anticancer drugs. Osawa T; Naito T; Suzuki N; Imai K; Nakanishi K; Kawakami J Talanta; 2011 Sep; 85(3):1614-20. PubMed ID: 21807230 [TBL] [Abstract][Full Text] [Related]
23. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device. Siderov J; Kirsa S; McLauchlan R J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949 [TBL] [Abstract][Full Text] [Related]
24. Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels. Fleury-Souverain S; Maurin J; Guillarme D; Rudaz S; Bonnabry P J Pharm Biomed Anal; 2022 Nov; 221():115034. PubMed ID: 36095884 [TBL] [Abstract][Full Text] [Related]
25. Validation and uncertainty estimation for trace amounts determination of 25 drugs used in hospital chemotherapy compounding units. Guichard N; Rudaz S; Bonnabry P; Fleury-Souverain S J Pharm Biomed Anal; 2019 Aug; 172():139-148. PubMed ID: 31035095 [TBL] [Abstract][Full Text] [Related]
26. Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process. Power LA; Sessink PJ; Gesy K; Charbonneau F Hosp Pharm; 2014 Apr; 49(4):355-62. PubMed ID: 24958942 [TBL] [Abstract][Full Text] [Related]
27. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation. Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041 [TBL] [Abstract][Full Text] [Related]
28. Development and validation of a liquid chromatography tandem mass spectrometry quantification method for 14 cytotoxic drugs in environmental samples. Acramel A; Chouquet T; Plé A; Sauvageon H; Mourah S; Jouenne F; Goldwirt L Rapid Commun Mass Spectrom; 2020 Feb; 34(4):e8594. PubMed ID: 31519060 [TBL] [Abstract][Full Text] [Related]
29. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals. Acampora A; Castiglia L; Miraglia N; Pieri M; Soave C; Liotti F; Sannolo N Ann Occup Hyg; 2005 Oct; 49(7):611-8. PubMed ID: 15964876 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of a closed-system cytotoxic transfer device in a pharmaceutical isolator. Vyas N; Turner A; Clark JM; Sewell GJ J Oncol Pharm Pract; 2016 Feb; 22(1):10-9. PubMed ID: 25073678 [TBL] [Abstract][Full Text] [Related]
31. A fully validated simple new method for environmental monitoring by surface sampling for cytotoxics. Rossignol E; Amiand MB; Sorrieul J; Bard JM; Bobin-Dubigeon C J Pharmacol Toxicol Methods; 2020; 101():106652. PubMed ID: 31734280 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement. Sottani C; Turci R; Schierl R; Gaggeri R; Barbieri A; Violante FS; Minoia C Rapid Commun Mass Spectrom; 2007; 21(7):1289-96. PubMed ID: 17340557 [TBL] [Abstract][Full Text] [Related]
34. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485 [TBL] [Abstract][Full Text] [Related]
35. [Detection of external contamination of methotrexate vials in an Argentine hospital]. Iglesias F Farm Hosp; 2006; 30(5):300-3. PubMed ID: 17166064 [TBL] [Abstract][Full Text] [Related]
36. Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations. Roberts S; Khammo N; McDonnell G; Sewell GJ J Oncol Pharm Pract; 2006 Jun; 12(2):95-104. PubMed ID: 16984748 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of decontamination efficacy of four antineoplastics (ifosfamide, 5-fluorouracil, irinotecan, and methotrexate) after deliberate contamination. Palamini M; Floutier M; Gagné S; Caron N; Bussières JF J Occup Environ Hyg; 2021 Feb; 18(2):43-50. PubMed ID: 33357045 [TBL] [Abstract][Full Text] [Related]
38. Surface contamination with ten antineoplastic drugs in 83 Canadian centers. Chauchat L; Tanguay C; Caron NJ; Gagné S; Labrèche F; Bussières JF J Oncol Pharm Pract; 2019 Jul; 25(5):1089-1098. PubMed ID: 29726786 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the efficacy of a self-cleaning automated compounding system for the decontamination of cytotoxic drugs. Telleria N; García N; Grisaleña J; Algaba N; Bergareche E; Tamés MJ; Cajaraville G J Oncol Pharm Pract; 2021 Sep; 27(6):1343-1353. PubMed ID: 32854575 [TBL] [Abstract][Full Text] [Related]
40. Environmental contamination with methotrexate in Canadian community pharmacies. Merger D; Tanguay C; Langlois É; Lefebvre M; Bussières JF J Am Pharm Assoc (2003); 2013; 53(4):423-6. PubMed ID: 23892817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]